News
AUA: Guideline on Surgical Management of BPH-Related Lower Urinary Tract Symptoms
The new guideline includes 22 recommendations focused on utilizing common surgical techniques and minimally invasive surgical therapies.
Your search for prostate returned 15 results
News
Imaging Agent Approved to Detect Recurrent Prostate Cancer
The approval of Axumin was based on two studies to evaluate the safety and efficacy.
News
Xtandi Label Updated to Include New Drug Comparison Data
The prescribing information for Xtandi (enzalutamide capsules; Astellas and Pfizer) has been updated to include new clinical data versus bicalutamide from the TERRAIN study.
News
AUA Discusses Antimicrobials, PSA Testing in New Choosing Wisely Recommendations
The American Urological Association (AUA) has issued a new list of recommendations as part of the Choosing Wisely campaign.
News
Menest Dosage Strength Discontinued
The Food and Drug Administration (FDA) reports the discontinuation of Menest (esterified estrogens; Pfizer) 2.5mg tablets.
News
FDA Approves Expanded Prostate Cancer Indication for Xtandi
The approval was based on data from the Phase 3 PROSPER trial which enrolled 1401 patients with non-metastatic CRPC.
News
Treatment With Homemade Enema Leads to Colitis in Two Children
A national survey showed that only about 7% of consumers read warning labeling on over-the-counter products.
News
Yonsa Approved for Metastatic Castration-Resistant Prostate Cancer
The approval of Yonsa was based on 2 randomized, placebo-controlled, multicenter Phase 3 studies in patients with mCRPC.
News
Mortality Risk Compared Among Men Receiving Drug Therapy for BPH/LUTS
Researchers conducted a retrospective matched cohort study to compare the risk of death among BPH patients treated with 5ARIs, as monotherapy or in combination with alpha-blockers, and those treated with alpha-blockers alone.
News
Bethanechol Prescribing Patterns Examined in Women With Bladder Dysfunction
While bethanechol, a cholinergic agonist, may "theoretically" improve detrusor contractility in women with underactive bladder (UAB), the evidence supporting its use is limited.
